Advertisement

Topics

NIH Awards $1.5M Grant to Help Devlop Rheumatoid Arthritis Vaccine

05:17 EDT 22 Sep 2017 | PharmPro

News
Related Biotechnology, Pharmaceutical and Healthcare News
CEL-SCI announces $1.5 million NIH SBIR grant to support development of rheumatoid arthritis vaccine. Previous pre-clinical studies show that LEAPS technology prevented the development, lessened the severity of arthritis.
Contributed Author: 
CEL-SCI Corporation
Topics: 
Drug Development

Original Article: NIH Awards $1.5M Grant to Help Devlop Rheumatoid Arthritis Vaccine

NEXT ARTICLE

More From BioPortfolio on "NIH Awards $1.5M Grant to Help Devlop Rheumatoid Arthritis Vaccine"

Give dad the gift of knowledge. Order his DNA Ancestry kit this Father's Day for $99 at 23andMe! Ord

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search
Advertisement
 

Relevant Topic

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...


News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

Biotech News by Location

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches


BioPortfolio Limited Social Media
Publish Content Agreements
Tools Help

HON Code certificate This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com.
All rights reserved. All other trademarks recognized. Copyright © 1997-2017 BioPortfolio Limited. Site developed by Alacrify Ltd.